The Revolutionary Intersection of AI and Drug Discovery

Last Thursday, I welcomed Dr. Daniel Karlsberg from the Princeton Longevity Center as a guest on Making Money With Matt McCall. He's a world-renowned cardiologist whose work in the field of longevity is crucial to preventive care.

And he just so happens to be my personal doctor.

Dr. Karlsberg and I discussed the areas within the multitrillion-dollar health care industry that will be disrupted by next-generation technologies. We talked about the importance of investing in yourself. And viewers even got to see a 3D rendering of my heart.

That was Part I of our health care-related podcast episodes. (If you haven't already, I highly suggest you watch it here.) As promised, Part II is dedicated to the industry's investment potential.

On today's new episode of Making Money With Matt McCall, I highlight four companies leading the push toward the future of health care by incorporating artificial intelligence ("AI") into the drug-discovery process.

Did you know that it takes about 10 years and more than $2 billion for a drug to move from the discovery stage to full approval from the U.S. Food and Drug Administration ("FDA")? And approximately 90% of drugs in testing never even make it that far.

Drug discovery is an expensive business with a low success rate. But thanks to AI, that's about to change...

This next-generation technology will help streamline the drug-discovery process – reducing the time it takes to get approval, lowering the cost of development, and helping create drugs for diseases that currently have no treatments.

Right now, it takes about three to five years to identify a drug-development candidate. But today, I tell you about two companies that believe they can identify a development candidate in less than one year. This is a massive improvement made possible by AI.

Now please note, all four of the companies that I discuss today are considered high risk.

That might not be your cup of tea, and that's OK. My goal is simply to present you with information that you can use to make your own investing decisions. And I'm not formally recommending any of these stocks for investment today.

Regardless, this is information you should have in your arsenal.

Tune in now to find out how AI is infiltrating the world of drug making and discovery... and to learn the names of the four companies leading the charge in this cutting-edge trend.

Click here to watch today's episode of Making Money With Matt McCall now.

Here's to the future,

Matt McCall
Editor, Daily Insight
April 11, 2023